Key Takeaways GLP-1 therapy can lead to average weight loss of 518% according to clinical trials
As shown in Figures 1B,C, both labeled GLP-1 (GLP-1-FAM) and exendin-4 (exendin-4-FAM) were detected in various brain regions (cerebellum, cortex, hippocampus, hypothalamus, and brain stem) 10 min after being infused into the peripheral circulation
Weight regain is possible if the medication is discontinued, so maintaining healthy lifestyle changes is crucial for long-term success.
The medication improves blood sugar, cholesterol, blood pressure, and inflammation
It's built to work on just one target, the skin's pigment switch, and its medical version is FDA-approved for a rare sun-sensitivity condition
To regain access, please make sure that cookies and JavaScript are enabled before reloading the page.